Literature DB >> 23284570

Intravitreal Bevacizumab for posterior capsule neovascularization.

Mansour Al-Mohaimeed.   

Abstract

Entities:  

Year:  2011        PMID： 23284570      PMCID： PMC3533354     

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN： 1658-3639


× No keyword cloud information.
  3 in total

1.  Photodynamic therapy for posterior capsule neovascularization.

Authors:  Ali Ayata; Melih Unal; Dilaver Erşanli; Oğuz Gülecek; Murat Sönmez
Journal:  J Cataract Refract Surg       Date:  2007-06       Impact factor: 3.351

2.  Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Authors:  Robert L Avery; Dante J Pieramici; Melvin D Rabena; Alessandro A Castellarin; Ma'an A Nasir; Matthew J Giust
Journal:  Ophthalmology       Date:  2006-02-03       Impact factor: 12.079

3.  Regression of neovascular posterior capsule vessels by intravitreal bevacizumab.

Authors:  Ebru Eren; Cem Küçükerdönmez; Gürsel Yilmaz; Yonca A Akova
Journal:  J Cataract Refract Surg       Date:  2007-06       Impact factor: 3.351
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.